// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























914 Abstracts

In Treated Patients with Idiopathic Pulmonary Fibrosis Hiatus Hernia but Not Acid Reflux Predicts Disease Progression and Survival

J. Mackintosh - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Idiopathic pulmonary fibrosis

Pirfenidone

Subacute Exacerbation of Idiopathic Pulmonary Fibrosis: Incidence, Characteristics and Outcomes

J. Caliez - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Idiopathic pulmonary fibrosis

N-acetylcysteine

Human Imaging of CCR2 Cell Inflammation in Idiopathic Pulmonary Fibrosis

S. L. Brody - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Frailty and Longitudinal Physiologic Outcomes in Older Patients with Idiopathic Pulmonary Fibrosis

J. S. Sheth - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Clinical Utility of Serum S100 Calcium Binding Protein A4 in Idiopathic Pulmonary Fibrosis

N. Akiyama - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

The MUC5B Promoter Polymorphism and Telomere Length in Chinese Patients with Idiopathic Pulmonary Fibrosis

H. Wang - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Associated Outcomes for IPF Patients with Lung Cancer

B. Bade - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Idiopathic pulmonary fibrosis

N/A

Social and Environmental Determinants of Lung Function in Patients with Idiopathic Pulmonary Fibrosis

K. A. Johannson - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

986020 in a Phase 2 Clinical Trial in Idiopathic Pulmonary Fibrosis

A. Minnich - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

BMS-986020

Barriers to the Diagnosis and Treatment of Interstitial Lung Diseases (ILD) in Colombia

O. M. Garcia Morales - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

986278, an LPA1 Receptor Antagonist for Idiopathic Pulmonary Fibrosis: Preclinical Assessments of Potential Hepatobiliary Toxicity

M. W. Gill - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

BMS-986020

Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis

J. G. Natalini - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Induced Stem Cell Failure and Lung Fibrosis Are Reversed by TUDCA

B. Zhou - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Tamoxifen

Lung Compliance Imaging: A Novel Imaging Parameter to Evaluate Lung Stiffness

G. Nair - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Distinct Blood Biomarkers Associate with Visual Evidence of Interstitial Lung Abnormality on HRCT in Both SPIROMICS and COPDGene

W. K. O'Neal - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Development of a Machine Learning Combination with Deep Learning for Diagnosing Idiopathic Pulmonary Fibrosis in Interstitial Lung Disease

T. Furukawa - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Bioanalytical Raman Spectral Cytometry of Alveolar Macrophages for the Quantitative Study of Idiopathic Pulmonary Fibrosis

V. LaLone - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Exploring the Shared Molecular Networks of COPD and Idiopathic Pulmonary Fibrosis Reveals Concordant and Discordant Pathways in the Interactome

A. Sharma - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

A Novel Interface for Sharing the Human Cell IPF Atlas

N. Neumark - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Unsupervised and Supervised Analysis to Identify Novel Candidate Genes and Therapeutics for Idiopathic Pulmonary Fibrosis

S. Ghandikota - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Copyright © 2026. QuantiNova All rights reserved